We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
+8.91%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$1.65B
AUM Growth
+$199M
Cap. Flow
+$85.4M
Cap. Flow %
5.17%
Top 10 Hldgs %
20.98%
Holding
2,136
New
85
Increased
550
Reduced
505
Closed
122
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OKTA icon
426
Okta
OKTA
$24.9B
$492K 0.03%
7,205
+1,377
+24% +$78.6K
GALT icon
427
Galectin Therapeutics
GALT
$212M
$491K 0.03%
434,800
-10,400
-2% -$13.9K
IHDG icon
428
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.24B
$489K 0.03%
13,732
+7,151
+109% +$271K
XLP icon
429
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$487K 0.03%
6,526
+1,298
+25% +$94.6K
VB icon
430
Vanguard Morningstar Small-Cap ETF
VB
$81.3B
$485K 0.03%
2,644
-21
-0.8% -$3.89K
BCE icon
431
BCE
BCE
$21.2B
$484K 0.03%
11,017
-3,579
-25% -$161K
ITW icon
432
Illinois Tool Works
ITW
$84.8B
$484K 0.03%
2,196
+188
+9% +$40K
NOC icon
433
Northrop Grumman
NOC
$80.7B
$483K 0.03%
885
+56
+7% +$29.2K
TBF icon
434
ProShares Short 20+ Year Treasury ETF
TBF
$105M
$481K 0.03%
21,200
-100
-0.5% -$2.26K
SPLK
435
DELISTED
Splunk Inc
SPLK
$477K 0.03%
5,544
-741
-12% -$59.8K
IVT icon
436
InvenTrust Properties
IVT
$2.6B
$472K 0.03%
19,942
-4,328
-18% -$103K
TEVA icon
437
Teva Pharmaceuticals
TEVA
$40.6B
$470K 0.03%
51,557
-3,100
-6% -$27K
MAIN icon
438
Main Street Capital
MAIN
$5.28B
$466K 0.03%
12,604
+1,960
+18% +$71.6K
SPDV icon
439
AAM S&P 500 High Dividend Value ETF
SPDV
$103M
$462K 0.03%
15,850
EUFN icon
440
iShares MSCI Europe Financials ETF
EUFN
$4.26B
$460K 0.03%
26,254
SLV icon
441
iShares Silver Trust
SLV
$29.8B
$456K 0.03%
20,705
-3,567
-15% -$69.9K
RTL
442
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$455K 0.03%
76,811
+7,062
+10% +$44.9K
TIP icon
443
iShares TIPS Bond ETF
TIP
$14.5B
$454K 0.03%
4,269
-693
-14% -$74K
ABNB icon
444
Airbnb
ABNB
$90B
$449K 0.03%
5,254
-150
-3% -$15.2K
HYZD icon
445
WisdomTree Trust WisdomTree Interest Rate Hedged High Yield Bond Fund
HYZD
$260M
$447K 0.03%
21,644
-1,020
-5% -$21.2K
GE icon
446
GE Aerospace
GE
$389B
$445K 0.03%
8,523
-321
-4% -$15.8K
SMDV icon
447
ProShares Russell 2000 Dividend Growers ETF
SMDV
$707M
$444K 0.03%
7,232
UWM icon
448
ProShares Ultra Russell2000
UWM
$244M
$439K 0.03%
14,109
-605
-4% -$19.9K
KKR icon
449
KKR & Co
KKR
$92.8B
$435K 0.03%
9,372
LDUR icon
450
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.37B
$431K 0.03%
4,569
+822
+22% +$77.3K

Similar funds

Geneos Wealth Management's Q4 2022 Portfolio in Review

As of Q4 2022, Geneos Wealth Management held 2,136 positions worth $1.65B, up 14% from $1.45B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Geneos Wealth Management deployed $85.4M of net new capital in Q4 2022, opening 85 new positions and adding to 550 existing holdings. Its largest new stake was Cambria Foreign Shareholder Yield ETF: 50,990 shares worth $1.24M.

By sector, the portfolio is most concentrated in Technology at 6.8% of assets, down from 7.4% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.88M trimmed.

  • Geneos Wealth Management's largest Q4 2022 buy was Cambria Foreign Shareholder Yield ETF: 50,990 shares worth $1.24M.
  • Geneos Wealth Management added most to iShares Russell 2000 ETF in Q4 2022, an estimated $7.83M increase.
  • Geneos Wealth Management's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.88M.
  • Geneos Wealth Management fully exited Brookfield in Q4 2022, selling an estimated $306K.
  • Geneos Wealth Management's ten largest holdings make up 21% of its $1.65B portfolio in Q4 2022.
  • Geneos Wealth Management opened 85 new positions and closed 122 in Q4 2022.
  • Geneos Wealth Management's portfolio value rose 14% quarter-over-quarter to $1.65B.

Based on Geneos Wealth Management's 13F filing for Q4 2022, filed 31 Jan 2023.